Meditrina Pharmaceuticals, Inc

About:

Meditrina Pharmaceuticals, a clinical-stage pharmaceutical company, develops innovative therapies that treat women's reproductive disorders.

Website: http://meditrina.com

Description:

Meditrina Pharmaceuticals, Inc. identifies and repurposes already marketed therapies and product candidates at advanced stages of development for new indications focused on improving women’s health disorders with unmet medical needs. The Company’s initial focus is in overlooked therapeutic areas that affect millions of women each year. These areas include gynecologic and aromatase-meditated conditions such as endometriosis and uterine fibroids.

Total Funding Amount:

$4.45M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Ann Arbor, Michigan, United States

Founded Date:

2006-01-01

Contact Email:

info(AT)meditrina.com

Founders:

Thomas A. Collet

Number of Employees:

1-10

Last Funding Date:

2010-12-27

IPO Status:

Private

Industries:

© 2025 bioDAO.ai